
The clinical study will evaluate a noninvasive corneal strengthening procedure designed to reshape the cornea and correct refractive errors in-office without tissue removal.

The clinical study will evaluate a noninvasive corneal strengthening procedure designed to reshape the cornea and correct refractive errors in-office without tissue removal.

A recent nonrandomized trial has demonstrated toric IOLs’ efficacy in providing long-term visual outcomes, reducing amblyopia compared to non-toric lenses.

Host Hamza Shah, OD, MS, FAAO, is joined by Austin Lifferth, OD, FAAO, to discuss interventional glaucoma, spurred by Funke et al's paper, "Interventional glaucoma consensus treatment protocol."

Clocking in for Workplace Eye Wellness Month means knowing the environmental factors contributing to a patient's dry eye.

Rachon, OD, FAAO, DipABO, details her SECO 2026 poster presentation, "Treatment of Stage 1 NK Secondary to Acoustic Neuroma Removal with Cryopreserved Amniotic Membrane."

Cathleen McCabe, MD, details what can be done now for these patients in a sea of imperfect options.


According to a VSP Vision Care news release, 71% say they experience performance impacts due to screen-related visual discomfort, equating to nearly one full workday of lost productivity each week.

The FDA has assigned a PDUFA goal date of October 17, 2026.


Vision rehabilitation includes training patients in the use of adaptive technologies, such as magnifiers or screen readers, and nonvisual techniques to facilitate the patients’ ability to complete daily tasks.

A recent study highlights the efficacy of the FAi implant in patients with NIU-related macular edema, improving BCVA and reducing choroidal thickness.

According to recent data, patients initiating semaglutide had a substantially greater risk of developing NAION versus those starting SGLT2 inhibitors.

Uveitis is a leading cause of blindness and accounts for an estimated 30,000 new cases of legal blindness annually in the US.

Rahul S. Tonk, MD, MBA, discussed his session on dry eye disease at EnVision Summit 2026, and looked ahead at the pipeline of therapies in development.

Alonso discusses his recent study highlighting pupil constriction in accommodative eye vergence as the central mechanism driving myopia progression.


Tonk, MD, MBA, references updates from TFOS DEWS III that promote standardized screening tools.

Pathik Amin, OD, FAAO, gave a presentation to the optometry cohort at the conference on glaucoma management, focusing on surgical options and recent advancements.

Julia Pulliam, OD, FAAO, highlights how working in an academic medical center provides significant advantages for managing complex conditions like uveitis.

The monthly multifocal toric lens with novel water gradient material targets presbyopic patients with astigmatism and is available to eye care professionals nationwide.

Improved guidance on preservatives and allergens needed to ensure safety.

This evidence-based eye care podcast seeks to turn research into practical clinical decisions, with new episodes on the first Monday of each month featuring expert guests across glaucoma, retina, dry eye, AI, and more.

For the patient with ocular surface discomfort, cataract surgery becomes a process rather than a single event.

McCabe, MD, presented alongside P. Dee Stephenson, MD, FACS, for the product theater titled "Know Your Dry Eye: Navigating the Challenges of Real-World Dry Eye Cases."

Pathik P. Amin, OD, FAAO, details his segment of an educational track session on glaucoma at this year's conference.

Metformin, a common diabetes medication, may be associated with less development of intermediate age-related macular degeneration (AMD).

Why school screenings fall short—and how your practice can fill the gap.

Jade Coats, OD, FAAO, and Cecelia Koetting, OD, FAAO, DipABO, provide a sneak peek into their 2-day session at the conference.